Baudax Bio, Inc. BXRX
0.02 USD 0.00 (+0.00%)
Feb 29, 2024, 3:53 PM EST
0.02 Day range 0.022025
0.0137 52-week range 3.47
- EPS (ttm)
- -94.13
- P/E ratio
- -0.00
- Volume
- 310.87K
- Avg volume
- 424.85K
- Open
- 0.0203
- Previous close
- 0.0218
- Day's range
- 0.02 – 0.022025
- 52-week range
- 0.0137 – 3.47
- Earnings date
- Mar 7, 2024
1Y -6.1736 (-97.07%)
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Mar 7, 2024
Expected Mar 7, 2024. Consensus EPS estimate 0.00.
Financials — quick view
BXRX Revenue — quarterly 0
BXRX Net income — quarterly -1.93M
BXRX EPS — quarterly -0.30
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 7, 2024 | Dec 1, 2023 | -0.12 | — | — | — |
| Nov 20, 2023 | Sep 1, 2023 | -0.53 | — | — | — |
| Aug 16, 2023 | Jun 1, 2023 | -2.04 | — | — | — |
| May 12, 2023 | Mar 1, 2023 | 5.75 | — | — | — |
| Feb 23, 2023 | Dec 1, 2022 | 0.00 | — | — | — |
| Nov 8, 2022 | Sep 1, 2022 | -21.20 | — | — | — |
News
12 Health Care Stocks Moving In Wednesday's After-Market Session 
Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session 
Baudax Bio Announces Corporate Update 
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session 
Stocks That Hit 52-Week Lows On Wednesday 
Baudax's (BXRX) Hemophilia A Drug Gets FDA's Orphan Drug Tag 
Why Is Baudax Bio (BXRX) Stock Up 75% Today? 
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session 
Baudax Bio shares rocket as lead clinical candidate gains FDA orphan drug designation 
Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
Your note
Sign in to keep a note on BXRX — it syncs with the Stock Master app.